Yvar Verhoeven case study
Yvar.jfif

Yvar Verhoeven

This photograph of the first recipient of 3BP for cancer, Yvar Verhoeven, in this Case Report was poised with the novel anticancer agent, 3-bromopyruvate (3BP) and his favorite legendary immortal bird, phoenix. The picture was taken on his 18th birthday, September 09, 2009, at his home in the Netherlands, after his 7th treatment with 3BP. This was a very special day as he had been told that he would never make it to his 17th birthday. 

The small alkylating molecule, 3-bromopyruvate (3BP), is a potent and specific anticancer agent. 3BP is different in its action from most currently available chemo-drugs. Thus, 3BP targets cancer cells' energy metabolism, both its high glycolysis ("Warburg Effect") and mitochondrial oxidative phosphorylation. This inhibits/ blocks total energy production leading to a depletion of energy reserves. Moreover, 3BP as an "Energy Blocker", is very rapid in killing such cells. 

ATP Synthasome_edited_edited.jpg
Yvar with Pedersen_edited.jpg

Yvar with Dr. Pedersen
at Johns Hopkins

This is the first of 3 short videos recorded in 2009, after Yvar completed his treatments with 3BP and was cancer free.   Click here to begin

Yvar continues his discussion with the class at Johns Hopkins

Yvar continues his discussion with the class of students at Johns Hopkins  Click here to continue

Yvar with Hopkins Class_edited.jpg
Yvar with Hopkins Class_edited.jpg

Yvar concludes his discussion with the students at Johns Hopkins

In this final short segment, Yvar wraps up his time with the students at Johns Hopkins before leaving on his trip to see the U.S. with his family.

Click here for the final segment